Cassella James V
SEC insider (Form 3/4/5 filer). CIK 0001353528. Chief Development Officer at Trevi Therapeutics, Inc. (TRVI). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in NEW HAVEN, CT.
Companies Cassella James V has filed insider reports for
- Trevi Therapeutics, Inc. (TRVI): Officer, Chief Development Officer
Cassella James V
CIK: 0001353528
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TRVI
Trevi Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 19, 2026TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
215K shares- - Feb 18, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
257.5K shares- - Sep 30, 2024TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
400K shares-
1-3 of 3 transactions